James Tsindos Anaphylaxis: Lessons Australia Cannot Ignore
James Tsindos, a 17-year-old with a known nut allergy, died in May 2021 after eating a vegan burrito bowl containing cashews. The coronial investigation revealed key failures in biphasic anaphylaxis recognition, delayed adrenaline administration, and a triage classification that underestimated his risk. This case highlights why adrenaline must come first, asthma does not rule out anaphylaxis, and hospital observation is essential even when a patient appears to stabilise.
In May 2021, a 17-year-old Year 12 student named James Tsindos ordered a vegan burrito bowl through a food delivery app. He had a known cashew nut allergy. The app did not clearly display the allergen information for that item. James consumed the meal, suffered a severe anaphylactic reaction, and despite receiving treatment from paramedics and hospital staff, he did not survive. The official cause of death, as determined by the subsequent coronial investigation, was hypoxic ischaemic encephalopathy - brain injury caused by prolonged oxygen deprivation following a biphasic anaphylactic reaction.
This article examines the findings from that coronial investigation and what they reveal about anaphylaxis management in Australia. It is written for anyone who wants to understand the clinical, systemic, and practical lessons that emerged from the inquest - including First Aid responders, healthcare professionals, food service workers, parents of children with severe allergies, and members of the public who carry or are near someone who carries an adrenaline autoinjector. The case of James Tsindos is not presented here to assign blame. It is presented because the coronial findings contain specific, actionable lessons that can save lives - and because those lessons are not yet universally understood or applied.
One of the most significant issues identified in the coronial inquest was biphasic anaphylaxis - a phenomenon where anaphylactic symptoms appear to resolve after initial treatment, only to return hours later without any further exposure to the allergen. James initially responded to adrenaline administered by paramedics. He appeared to stabilise. But the second phase arrived, and the clinical response to that second phase became another focal point of the inquest. The findings explored whether James was triaged appropriately on arrival at the emergency department, whether the handover from paramedics to hospital staff was effective, and whether additional adrenaline was administered quickly enough when symptoms recurred.
A second major theme running through the case was the dangerous overlap between asthma and anaphylaxis. James had pre-existing asthma. When a wheeze developed during his deterioration, there was a question of whether it was being treated as an asthma episode rather than as a sign of worsening anaphylaxis. This distinction is critical because the treatment priority differs significantly. In suspected anaphylaxis, current Australian guidelines are clear: adrenaline is the first-line treatment. Not Ventolin. Not a period of observation. Adrenaline first. When the two conditions overlap, as they can and do, recognising which is driving the deterioration - and responding accordingly - can determine the outcome.
The findings also raised important questions about food allergen disclosure in the online food delivery space. Vegan food is not automatically allergen-free. Cashews, almonds, and other tree nuts are widely used in vegan cooking to replicate dairy-based textures in sauces, creams, and cheeses. For someone with a severe nut allergy, ordering from a vegan menu without verifying full ingredient information carries real risk. The inquest highlighted how app-based ordering systems may present ingredient information in ways that require the user to actively navigate deeper into each menu item - something many people do not do, and something that may not be consistently designed to prompt allergen awareness.
